SynthesisFrontiers in oncology2021

The Risk of Immune-Related Thyroid Dysfunction Induced by PD-1/PD-L1 Inhibitors in Cancer Patients: An Updated Systematic Review and Meta-Analysis.

Yuan Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.